Article

Susan Urba, MD, Addresses Risks Associated with Untreated Chemotherapy-Induced Nausea and Vomiting

"There is a substantial number of risks associated with chemotherapy-induced nausea and vomiting (CINV)," said Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan.

"There is a substantial number of risks associated with chemotherapy-induced nausea and vomiting (CINV)," said Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan. The patient's quality-of-life is the main risk and concern of untreated CINV. Dr Urba also discusses the cost issues associated with uncontrolled CINV. Patient education is crucial in the prevention of unnecessary costs from extra office visits or hospitalization.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Dr Pankit Vachhani
Dr Ibrahim Aldoss
Dr Pankit Vachhani
Mansi Shah, MD
Dr John Mascarenhas
CK Wang, MD, COTA
Dr Pankit Vachhani
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Merrill H. Stewart, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo